Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim
SGLT2i in Kidney Stones (clinicaltrials.gov) - Sep 5, 2026 - P1 | N=32 | Recruiting | Sponsor: University of Chicago | Trial completion date: Dec 2027 ➔ Nov 2028 | Trial primary completion date: Nov 2027 ➔ Nov 2028 
Trial completion date • Trial primary completion date • Nephrology • Renal Calculi
http://clinicaltrials.gov/ct2/show/NCT07055282
 
Sep 5, 2026
 
Prev Next